Related Experiment Video
Updated: Sep 28, 2026

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice
Published on: June 15, 2020
Hypertension, left ventricular hypertrophy, and sudden death
Lwin Lwin Tin1, D Gareth Beevers, Gregory Y H Lip
1Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Dudley Road, Birmingham B18 7QH, UK.
Insights
Left ventricular hypertrophy (LVH) increases sudden cardiac death (SCD) risk through thrombotic/ischemic or arrhythmic mechanisms. Research is exploring LVH regression and its prognostic benefits for hypertension patients.
Area of Science:
- Cardiology
- Hypertension Research
- Sudden Cardiac Death
Background:
- Left ventricular hypertrophy (LVH) is a key indicator of end-organ damage in hypertension.
- LVH is significantly associated with an increased incidence of sudden cardiac death (SCD).
Purpose of the Study:
- To review the potential mechanisms linking LVH to SCD.
- To explore the role of thrombotic/ischemic and arrhythmic factors in SCD among hypertensive patients with LVH.
- To examine the impact of LVH regression on patient prognosis.
Main Methods:
- Literature review of studies investigating the relationship between LVH and SCD.
- Analysis of mechanisms including endothelial dysfunction, hypercoagulable state, and electrophysiologic abnormalities.
- Evaluation of research on LVH regression and its prognostic implications.
Main Results:
- SCD in LVH may stem from thrombotic/ischemic events or arrhythmias.
- Myocardial ischemia, even without significant coronary artery disease, is a potential factor.
- Abnormalities in flow-mediated dilatation, endothelial function, and hypercoagulability are observed in hypertension with LVH.
- Electrophysiologic abnormalities predispose LVH patients to arrhythmias.
Conclusions:
- LVH presents multiple potential pathways contributing to SCD in hypertensive individuals.
- Further research is needed to define the exact role of vascular and hemostatic abnormalities in SCD pathogenesis.
- Investigating LVH regression is crucial for understanding potential prognostic benefits and improving outcomes.
Abstract:
Left ventricular hypertrophy (LVH), a form of end-organ damage in hypertension, is associated with increased incidence of sudden cardiac death (SCD). This review explores the possible mechanisms behind this phenomenon. SCD in LVH could be thrombotic/ischemic or arrhythmic (eg, myocardial ischemia, even in the absence of significant coronary artery disease, may be one important factor). Abnormalities of flow-mediated dilatation, endothelial function, and a hypercoagulable state are well-observed abnormalities in association with hypertension and LVH, although their precise contributory role is as yet undefined in the pathogenesis of sudden death. Electrophysiologic abnormalities are also well documented in LVH, and such patients are more predisposed to arrhythmias. In the past decade, many studies have investigated the regression of LVH, and recent studies are addressing whether the latter translates into a prognostic benefit.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Regurgitation I: Introduction
Heart Failure II: Pathophysiology
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Stenosis I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies

